Header Logo

Connection

Gary Holland to Cytomegalovirus Retinitis

This is a "connection" page, showing publications Gary Holland has written about Cytomegalovirus Retinitis.
Connection Strength

5.161
  1. Relationship Between Opacity of Cytomegalovirus Retinitis Lesion Borders and Severity of Immunodeficiency Among People With AIDS. Invest Ophthalmol Vis Sci. 2019 05 01; 60(6):1853-1862.
    View in: PubMed
    Score: 0.590
  2. AIDS and ophthalmology: the first quarter century. Am J Ophthalmol. 2008 Mar; 145(3):397-408.
    View in: PubMed
    Score: 0.272
  3. Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1988 to 1994). Am J Ophthalmol. 2008 Jan; 145(1):5-11.
    View in: PubMed
    Score: 0.269
  4. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Am J Ophthalmol. 2008 Jan; 145(1):12-22.
    View in: PubMed
    Score: 0.269
  5. Argon laser demarcation of AIDS-related cytomegalovirus retinitis in resource-limited setting. Int Ophthalmol. 2026 Mar 19; 46(1).
    View in: PubMed
    Score: 0.238
  6. Clear lens extraction with intraocular lens implantation during retinal detachment repair in patients with Acquired Immune Deficiency Syndrome (AIDS) [correction of autoimmune deficiency syndrome] and cytomegalovirus retinitis. Ophthalmology. 2002 Apr; 109(4):666-73.
    View in: PubMed
    Score: 0.181
  7. Immune recovery uveitis. Am J Ophthalmol. 2000 Jul; 130(1):103-6.
    View in: PubMed
    Score: 0.160
  8. New issues in the management of patients with AIDS-related cytomegalovirus retinitis. Arch Ophthalmol. 2000 May; 118(5):704-6.
    View in: PubMed
    Score: 0.158
  9. Contralateral Eye Involvement and Retinal Detachment in Patients with Cytomegalovirus Retinitis Treated with Intravitreous Ganciclovir. Ocul Immunol Inflamm. 2021 Aug 18; 29(6):1145-1150.
    View in: PubMed
    Score: 0.157
  10. Treatment options for cytomegalovirus retinitis: a time for reassessment. Arch Ophthalmol. 1999 Nov; 117(11):1549-50.
    View in: PubMed
    Score: 0.153
  11. Cytomegalovirus retinitis--evolving therapies in a new era. N Engl J Med. 1999 Apr 08; 340(14):1109-10.
    View in: PubMed
    Score: 0.147
  12. Therapeutic decisions: informed choices in a changing clinical environment. Am J Ophthalmol. 1999 Mar; 127(3):327-8.
    View in: PubMed
    Score: 0.146
  13. Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology. 1999 Jan; 106(1):133-41.
    View in: PubMed
    Score: 0.144
  14. Visual acuity outcomes in cytomegalovirus retinitis: early versus late diagnosis. Br J Ophthalmol. 2018 12; 102(12):1607-1610.
    View in: PubMed
    Score: 0.141
  15. Active cytomegalovirus retinitis after the start of antiretroviral therapy. Br J Ophthalmol. 2019 02; 103(2):157-160.
    View in: PubMed
    Score: 0.141
  16. Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy. Am J Ophthalmol. 2017 Feb; 174:23-32.
    View in: PubMed
    Score: 0.124
  17. Endogenous bacterial endophthalmitis as a complication of intravenous therapy for cytomegalovirus retinopathy. Arch Ophthalmol. 1996 Jul; 114(7):879-80.
    View in: PubMed
    Score: 0.121
  18. Risk factors for CMV retinitis among individuals with HIV and low CD4 count in northern Thailand: importance of access to healthcare. Br J Ophthalmol. 2016 08; 100(8):1017-21.
    View in: PubMed
    Score: 0.121
  19. Cytomegalovirus retinitis: are intraocular devices the answer? Br J Ophthalmol. 1995 Dec; 79(12):1066-7.
    View in: PubMed
    Score: 0.116
  20. New therapies for cytomegalovirus retinitis. N Engl J Med. 1995 Sep 07; 333(10):658-9.
    View in: PubMed
    Score: 0.115
  21. Local therapy for cytomegalovirus retinopathy. Am J Ophthalmol. 1995 Sep; 120(3):376-85.
    View in: PubMed
    Score: 0.114
  22. Dose-related difference in progression rates of cytomegalovirus retinopathy during foscarnet maintenance therapy. AIDS Clinical Trials Group Protocol 915 Team. Am J Ophthalmol. 1995 May; 119(5):576-86.
    View in: PubMed
    Score: 0.112
  23. Telemedicine screening for cytomegalovirus retinitis at the point of care for human immunodeficiency virus infection. JAMA Ophthalmol. 2015 Feb; 133(2):198-205.
    View in: PubMed
    Score: 0.110
  24. Retinal detachment associated with AIDS-related cytomegalovirus retinitis: risk factors in a resource-limited setting. Am J Ophthalmol. 2015 Jan; 159(1):185-92.
    View in: PubMed
    Score: 0.108
  25. Telemedicine diagnosis of cytomegalovirus retinitis by nonophthalmologists. JAMA Ophthalmol. 2014 Sep; 132(9):1052-8.
    View in: PubMed
    Score: 0.107
  26. Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review. Clin Infect Dis. 2013 Nov; 57(9):1351-61.
    View in: PubMed
    Score: 0.099
  27. Clinical features of newly diagnosed cytomegalovirus retinitis in northern Thailand. Am J Ophthalmol. 2012 May; 153(5):923-931.e1.
    View in: PubMed
    Score: 0.089
  28. Accuracy and reliability of telemedicine for diagnosis of cytomegalovirus retinitis. Am J Ophthalmol. 2011 Dec; 152(6):1053-1058.e1.
    View in: PubMed
    Score: 0.087
  29. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis. Ophthalmology. 2006 Apr; 113(4):683.e1-8.
    View in: PubMed
    Score: 0.060
  30. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006 Apr; 113(4):684-94.
    View in: PubMed
    Score: 0.060
  31. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy. HIV Clin Trials. 2005 May-Jun; 6(3):136-46.
    View in: PubMed
    Score: 0.056
  32. Clinician versus reading center assessment of cytomegalovirus retinitis lesion size. Ophthalmology. 2005 Apr; 112(4):559-66.
    View in: PubMed
    Score: 0.056
  33. Ischemic maculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 2001 Nov; 132(5):727-33.
    View in: PubMed
    Score: 0.044
  34. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy. J Infect Dis. 2001 May 01; 183(9):1399-404.
    View in: PubMed
    Score: 0.042
  35. Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group. Arch Ophthalmol. 2000 Sep; 118(9):1196-204.
    View in: PubMed
    Score: 0.040
  36. Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 01; 17(4):339-44.
    View in: PubMed
    Score: 0.034
  37. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol. 1998 Mar; 125(3):292-300.
    View in: PubMed
    Score: 0.034
  38. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med. 1997 Feb 15; 126(4):257-63.
    View in: PubMed
    Score: 0.032
  39. Bilateral endogenous Fusarium endophthalmitis associated with acquired immunodeficiency syndrome. Arch Ophthalmol. 1996 Jul; 114(7):873-7.
    View in: PubMed
    Score: 0.030
  40. Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology. 1994 Mar; 101(3):499-507.
    View in: PubMed
    Score: 0.026
  41. Combination of ganciclovir and granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients. The ACTG 073 Team. Eur J Clin Microbiol Infect Dis. 1994; 13 Suppl 2:S34-40.
    View in: PubMed
    Score: 0.025
  42. Hemorheologic abnormalities associated with HIV infection: in vivo assessment of retinal microvascular blood flow. Invest Ophthalmol Vis Sci. 2006 Sep; 47(9):3933-8.
    View in: PubMed
    Score: 0.015
  43. Increased polymorphonuclear leucocyte rigidity in HIV infected individuals. Br J Ophthalmol. 2000 Jul; 84(7):727-31.
    View in: PubMed
    Score: 0.010
  44. Vitrectomy and silicone oil tamponade for cidofovir-associated hypotony with ciliary body detachment. Retina. 1999; 19(1):75-6.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.